Air pollution and Alzheimer disease phenotype deplete esterified proresolving lipid mediator reserves in the brain
Authors:
- Ameer Y. TahaATAmeer Y. Taha
- Qing ShenQSQing Shen
- Yurika OtokiYOYurika Otoki
- Nuanyi LiangNLNuanyi Liang
- Kelley T. PattenKPKelley T. Patten
- Anthony E. ValenzuelaAVAnthony E. Valenzuela
- Christopher D. WallisCWChristopher D. Wallis
- Douglas J. RowlandDRDouglas J. Rowland
- Abhijit J. ChaudhariACAbhijit J. Chaudhari
- Keith J. BeinKBKeith J. Bein
- Anthony S. WexlerAWAnthony S. Wexler
- Lee-Way JinLJLee-Way Jin
Open Access
- 13 May 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (15)
Abstract
BACKGROUND: Traffic-related air pollution (TRAP) is a risk factor for Alzheimer disease (AD), where unresolved brain inflammation has been linked to deficits in the levels of free lipid mediators that enable the resolution of inflammation. It is unknown whether these deficits are due to reductions in esterified lipid pools, the main source of free bioactive proresolving lipids in the brain, and whether they are related AD pathophysiology. METHODS: This unknown was tested by measuring brain esterified lipid mediators and pathogenic markers of AD in TgF344-AD and WT male and female rats exposed to filtered air or TRAP for 14 months; it was also tested in human postmortem prefrontal cortex of individuals with or without AD. RESULTS: Significant reductions in proresolving lipid mediators esterified to neutral lipids and/or phospholipids were seen in AD and TRAP-exposed female rats, where levels were associated with inflammation, synaptic loss, and impaired glucose metabolism. Lower esterified proresolving lipid mediator concentrations were associated with older age in prefrontal cortex of humans with AD compared with controls. CONCLUSION: Impaired resolution in AD is due to depletion of esterified proresolving lipid pools that supply the brain with free bioactive mediators involved in inflammation resolution. TRAP exposure alters the same esterified resolution pathways, reflecting convergent mechanisms underlying AD.Keywords
Funding Information
- Alzheimer's Association (2018-AARGD-591676)
- National Institutes of Health (T32 MH112507)
- National Institutes of Health (T32 ES007059)
- Chan Zuckerberg Initiative (2019-198156)
- National Institutes of Health (R21 ES026515,R21 ES025570,P30 ES023513,P30 AG010129,P30 AG072972,RF1 AG074709,RF1 NS130659,)
- National Institutes of Health (R21 AG064599)
This publication has 89 references indexed in Scilit:
- Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organsBrain Research, 1999
- 15‐Lipoxygenation of phospholipids may precede the sn‐2 cleavage by phospholipases A2: reaction specificities of secretory and cytosolic phospholipases A2 towards native and 15‐lipoxygenated arachidonoyl phospholipidsFEBS Letters, 1998
- Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brainNeuroscience, 1998
- Incidence and Risk of Dementia: The Rotterdam studyAmerican Journal of Epidemiology, 1998
- Circulating cytokines in Alzheimer's diseaseJournal of Psychiatric Research, 1997
- The applications of PET in clinical oncology.1991
- Lung retention of antimony and arsenic in hamsters after the intratracheal instillation of industrial dust.Scandinavian Journal of Work, Environment & Health, 1984
- The Fluorodeoxyglucose 18F Scan in Alzheimer's Disease and Multi-infarct DementiaArchives of Neurology, 1983
- The influence of immaturity on hypoxic‐ischemic brain damage in the ratAnnals of Neurology, 1981
- AChE-stained horizontal sections of the rat brain in stereotaxic coordinatesJournal of Neuroscience Methods, 1980